An award has been made to Dr. Robert Fleischmann at TIGR by the NIAID under the announcement "Innovative Drug Discovery in AIDS Opportunistic Infections" for the complete genome sequenceing of a strain of Mycobacterium avium

An award has been made to Dr. Robert Fleischmann at TIGR by the NIAID under the announcement "Innovative Drug Discovery in AIDS Opportunistic Infections" for the complete genome sequenceing of a strain of Mycobacterium avium. Before library construction and sequencing begins, NIAID is seeking input from the research community on the strain selection. Please go to NIAID Latest News for a description of strain selection criteria and to submit your input.